Cargando…
How Charge, Size and Protein Corona Modulate the Specific Activity of Nanostructured Lipid Carriers (NLC) against Helicobacter pylori
The major risk factor associated with the development of gastric cancer is chronic infection with Helicobacter pylori. The available treatments, based on a cocktail of antibiotics, fail in up to 40% of patients and disrupt their gut microbiota. The potential of blank nanostructured lipid carriers (N...
Autores principales: | Chitas, Rute, Nunes, Cláudia, Reis, Salette, Parreira, Paula, Martins, Maria Cristina L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9785867/ https://www.ncbi.nlm.nih.gov/pubmed/36559239 http://dx.doi.org/10.3390/pharmaceutics14122745 |
Ejemplares similares
-
Effect of compositions in nanostructured lipid carriers (NLC) on skin hydration and occlusion
por: Loo, CH, et al.
Publicado: (2013) -
In Vitro Studies on Nasal Formulations of Nanostructured Lipid Carriers (NLC) and Solid Lipid Nanoparticles (SLN)
por: Costa, Cláudia Pina, et al.
Publicado: (2021) -
EGCG intestinal absorption and oral bioavailability enhancement using folic acid-functionalized nanostructured lipid carriers
por: Granja, Andreia, et al.
Publicado: (2019) -
Design of a nanostructured lipid carrier intended to improve the treatment of tuberculosis
por: Pinheiro, Marina, et al.
Publicado: (2016) -
Sucupira Oil-Loaded Nanostructured Lipid Carriers (NLC): Lipid Screening, Factorial Design, Release Profile, and Cytotoxicity
por: Vieira, Raquel, et al.
Publicado: (2020)